Revenue performance remains erratic, characterized by a 99.6% contraction in 2026Q2 followed by a massive surge, while gross margins remain compressed at 25.1% as of 2026Q3 due to physical trading activities.
| Sales/Revenue | 54.63M | 15.6M | 42.71M | 13.85M | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 136.12% | -63.48% | 208.26% | - | - | - | - | - | - |
| Cost of Goods Sold | 44.94M | 14.04M | 29.75M | 12.96M | 2K | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | 90.02% | 69.67% | 93.54% | - | - | - | - | - |
| Gross Profit | 9.68M | 1.56M | 12.95M | 895K | -2K | 0 | 0 | 0 | 0 |
| Gross Margin % | 17.72% | 9.98% | 30.33% | 6.46% | - | - | - | - | - |
| Gross Profit Growth % | - | -87.99% | 1347.04% | 44850% | - | - | - | - | - |
| Operating Expenses | 7.89M | 6.36M | 5.87M | 4.68M | 5.49M | 1.47M | 2.27M | 1.34M | 322.06K |
| OpEx % of Revenue | - | 40.8% | 13.75% | 33.76% | - | - | - | - | - |
| Selling, General & Admin | 7.42M | 7.84M | 5.87M | 4.68M | 5.49M | 1.47M | 2.27M | 1.34M | 322.06K |
| SG&A % of Revenue | - | 50.3% | 13.75% | 33.76% | - | - | - | - | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 466K | -1.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 1.8M | -4.81M | 7.08M | -3.78M | -5.49M | -1.47M | -2.27M | -1.34M | -322.06K |
| Operating Margin % | 3.29% | -30.82% | 16.57% | -27.3% | - | - | - | - | - |
| Operating Income Growth % | - | -167.91% | 287.12% | 31.15% | -272.59% | 35.06% | -69.32% | -316.35% | - |
| EBITDA | 1.98M | -4.69M | 7.1M | -3.76M | -5.49M | -1.85M | -1.63M | -390.66K | -322.06K |
| EBITDA Margin % | 3.63% | -30.05% | 16.63% | -27.13% | - | - | - | - | - |
| EBITDA Growth % | 364.28% | -166% | 288.93% | 31.56% | -196.04% | -13.96% | -316.65% | -21.3% | - |
| D&A (Non-Cash Add-back) | 186.06K | 120K | 23K | 24K | 2K | 0 | 0 | 0 | 0 |
| EBIT | 5.08M | -4.87M | 7.77M | -4.22M | -5.73M | -1.85M | -1.63M | -390.66K | -322.06K |
| Net Interest Income | 1.09M | 139K | 683K | -1.57M | -685K | 56K | 0 | 0 | 0 |
| Interest Income | 1.1M | 575K | 692K | 67K | 37K | 56K | 0 | 0 | 0 |
| Interest Expense | 16.01K | 436K | 9K | 1.64M | 722K | 0 | 0 | 3.68M | 0 |
| Other Income/Expense | 1.95M | -502K | 680K | -2.08M | -956K | -380.55K | -559.09K | -2.73M | 0 |
| Pretax Income | 3.74M | -5.31M | 7.76M | -5.86M | -6.45M | -1.85M | -2.83M | -4.07M | -322.06K |
| Pretax Margin % | 6.85% | -34.04% | 18.16% | -42.28% | - | - | - | - | - |
| Income Tax | -646.56K | 346K | -2.02M | -15K | -2.19M | -478.32K | -128.13K | -250.36K | 0 |
| Effective Tax Rate % | -17.28% | -6.52% | -26.08% | 0.26% | 33.99% | 25.79% | 4.53% | 6.15% | 0% |
| Net Income | 4.39M | -5.65M | 9.78M | -5.84M | -4.26M | -1.38M | -2.7M | -3.82M | -322.06K |
| Net Margin % | 8.03% | -36.26% | 22.9% | -42.18% | - | - | - | - | - |
| Net Income Growth % | 307.81% | -157.81% | 267.38% | -37.26% | -209.26% | 49.04% | 29.28% | -1085.98% | - |
| Net Income (Continuing) | 4.39M | -5.65M | 9.78M | -5.84M | -4.26M | -1.38M | -2.7M | -3.82M | -322.06K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.03 | -0.04 | 0.08 | -0.06 | -0.05 | -0.02 | -0.05 | -0.09 | -0.01 |
| EPS Growth % | 199.01% | -152.59% | 242.04% | -23.86% | -152.36% | 61.57% | 45.38% | - | - |
| EPS (Basic) | - | -0.04 | 0.09 | -0.06 | -0.05 | -0.02 | -0.05 | -0.09 | -0.01 |
| Diluted Shares Outstanding | 142.08M | 126.8M | 115.33M | 97.95M | 88.27M | 72.03M | 54.32M | 41.96M | 41.96M |
| Basic Shares Outstanding | 141.38M | 126.8M | 108.64M | 97.95M | 88.27M | 72.03M | 54.32M | 41.96M | 41.96M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
High Revenue Volatility
As reported in financial statements, UROY's top-line performance exhibits extreme volatility, highlighted by a 4170.6% revenue surge in 2026Q3 following a 99.6% contraction in 2026Q2, reflecting the lumpy nature of physical uranium inventory sales rather than consistent, organic growth from the underlying royalty portfolio assets.
The massive fluctuations in quarterly revenue suggest that the company's current business model is heavily reliant on opportunistic trading rather than predictable royalty streams. Investors should monitor whether future revenue stabilizes as the underlying Tier-1 assets like McArthur River and Langer Heinrich reach steady-state production levels.
Based on recent SEC filings, UROY's gross margins have fluctuated significantly, reaching a low of 3.8% in 2025Q4, which indicates that the company's profitability is currently tethered to the low-margin physical uranium trading segment rather than the high-margin royalty interests typical of the broader sector.
The disparity between UROY's gross margins and those of established royalty peers like Franco-Nevada suggests that the current revenue mix is dilutive to long-term profitability. A sustained improvement in margins appears contingent upon a shift toward pure royalty income and a reduction in the reliance on physical inventory turnover.
According to historical income statement data, UROY's operating income frequently turns negative, as seen in the -78.6% operating margin in 2026Q2, suggesting that the company's fixed corporate overhead is currently too high to be efficiently absorbed by the existing, intermittent royalty and trading revenue streams.
The inability to consistently scale operating income alongside gross profit indicates a lack of operational leverage in the current business model. Management must demonstrate an ability to control SG&A expenses as the portfolio matures to avoid persistent operating losses during periods of lower inventory sales.
Based on reported figures, the company's reliance on physical uranium sales to drive top-line growth warrants further investigation, as the 2026Q3 revenue spike appears disconnected from the core royalty business, potentially masking underlying weaknesses in the long-term cash-generating capacity of the current asset portfolio.
Short-term revenue volatility may obscure the true performance of the royalty interests, making it difficult for investors to assess the company's intrinsic value. The market should remain cautious regarding whether the current revenue model can provide the perpetual, high-margin cash flows expected from a pure-play royalty vehicle.
Quick answers to the most common questions about buying UROY stock.
For fiscal year 2025, Uranium Royalty Corp. (UROY) reported total revenue of $15.6M.
Uranium Royalty Corp. (UROY) reported a net loss of $5.7M for the fiscal year ending 2025.
Uranium Royalty Corp. (UROY) reported an operating income of $-4.8M, resulting in an operating profit margin of -30.8%. This margin reflects the operational efficiency of the business before interest and taxes.
Uranium Royalty Corp. (UROY) generated $1.6M in gross profit for the year, representing a gross profit margin of 10.0%. This demonstrates the company's core pricing power and production efficiency.